SUNPHARMA Charts, Analysis and Tips

home > pharma-and-healthcare > pharmaceuticals > sunpharma

Technical Analysis

Technical Strength: 7.9 / 10
Indicator Analysis Signal (0 - 10) Chart
RSI (?) RSI is 66.9. According to RSI analysis, sunpharma is technically strong. 9.0 SUNPHARMA RSI Chart
MACD (?) MACD: 7.94 and Signal Line: 5.47. According to MACD analysis, sunpharma is technically strong. 8.0 SUNPHARMA MACD Chart
Simple Moving Average (?) According to simple moving average analysis, sunpharma is in a uptrend. Support level is at 429. 9.0 SUNPHARMA Simple Moving Average Chart
Exponential Moving Average (?) According to exponential moving average analysis, sunpharma is in a uptrend. Support level is at 434. 9.0 SUNPHARMA Exponential Moving Average Chart
Bollinger Bands (?) %b is 0.986. According to bollinger bands, sunpharma is technically strong. 7.0 SUNPHARMA Bollinger Bands Chart
Fibonacci Retracement (?) According to fibonacci retracement, price is above all levels. Major support is at 440.9664 and 434.5. Resistance level is 461.9. 6.5 SUNPHARMA Fibonacci Retracement Chart
Average True Range (?) ATR: 14.8 NA SUNPHARMA Average True Range Chart
Average Directional Index (?) ADX is 26.4 which means SUNPHARMA is in a trend. NA SUNPHARMA Average Directional Index Chart
Note: Technical Analysis updated at 7PM on every trading day.
End-of-Day Share Price - NSE
November 22, 2019
Open Price 450.0
High Price 461.9
Low Price 445.1
Close Price 452.1
Absolute Change 4.95
Percentage Change 1.11%
Weekly Change 8.93%
Monthly Change 11.4%
Yearly Change -23.3%
52-week high 592.9
52-week low 344.55
Corporate Actions
ExDate Purpose
August 20, 2019 AGM/DIV-RS 2.75 PER SH
September 17, 2018 AGM/DIV RS 2 PER SHARE
September 18, 2017 AGM/DIV-RS 3.50 PER SHARE
See all Corporate Actions
Volume Chart
Real time prices can be delayed by 20 minutes. Prices are refreshed from our server automatically after 1 minute. If NSE real time price is not available then BSE real time prices are provided. Volume displayed might not be correct..

Fundamental Analysis

Beta (?)0.582
Confidence in Beta1.54%
Market Capital Rs. 93629.0 Cr
Whenever available, consolidated financial results are used. For details, see here.
Stock Deliverable Quantity and Daily Volatility
Indicator Analysis Signal (0 - Strong Sell, 10 - Strong Buy) Chart
Deliverable Quantity (?) 22 November 2019: Deliverable Quantity:1.97e+06 NA SUNPHARMA Deliverable Quantity Chart
Annualized Daily Volatility (Spot Price) (?) 22 November 2019: Daily Volatility:0.3859 NA SUNPHARMA Annualized Daily Volatility (Spot Price) Chart

Futures & Options Analysis

Indicator Analysis Signal (0 - Strong Sell, 10 - Strong Buy) Chart
PCR (?) 22 November 2019: PCR_OI:0.458 PCR:0.383 NA SUNPHARMA PCR Chart
Option Pain (?) 22 November 2019: Max Pain:440.0 NA SUNPHARMA Option Pain Chart
Premium (?) 22 November 2019 Premium: -0.5 Futures OI:52215900.0 NA SUNPHARMA Premium Chart
Option_MAX_OI (?) 22 November 2019: Price:452.1 Put with maximum OI:430.0 Call with maximum OI:460.0 NA SUNPHARMA Option_MAX_OI Chart

Futures - NSE

Expiry Date Close Price Open Interest Number of Trades No of Contracts Underlying Closing Price
November 28, 2019 451.6 52215900.0 17117.0 17117.0 452.1
December 26, 2019 454.0 12445400.0 4379.0 4379.0 452.1
January 30, 2020 456.25 53750.0 22.0 22.0 452.1


September 12, 2018 News Clarification The Exchange has sought clarification from the Company with respect to news item captioned-Sun Pharma Mohali plant on FDA radar In this regard, Exchange has advised the Company to provide clarification/confirmation on the news item in detail including the following: a) Whether such event/negotiations/article stated in published news were taking place? If so, you are advised to provide the said information along with the sequence of events in chronological order and the material impact of this article on the Company. b) Whether company is aware of any information that has not been announced to the Exchanges under regulation 30 of Listing Regulations. The response from the Company is awaited.
April 26, 2018 SShareholders meetingSun Pharmaceutical Industries Limited has informed the Exchange regarding Notice of Court Convened General Meeting to be held on Jun 01, 2018
See all Announcements

Board Meetings

Date Meeting Date Purpose
October 23, 2019 November 07, 2019 Financial Results To consider and approve the financial results for the period ended September 30, 2019
July 29, 2019 August 13, 2019 Financial Results To consider and approve the financial results for the period ended Jun 30, 2019
See all Board Meetings

SUNPHARMA is part of...

Index Weightage

Get Clearnifty's Android App.

Get clearnifty on Google Play
Get clearnifty on Google Play